Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2024-08-23 08:00:00
Lytix Biopharma AS (Euronext Growth Oslo: LYTIX), a leading Norwegian
immuno-oncology company, will release its second quarter 2024 financial results
on Thursday, 29 August 2024.
Date: Thursday, 29 August 2024
Time: 10:00 AM CET
Join us for a live webcast presentation featuring CEO Øystein Rekdal and CFO
Gjest Breistein, where they will discuss the results and provide key insights.
Q&A Session:
We welcome your questions in advance. Please send them to
post@lytixbiopharma.com, and they will be addressed during the Q&A session
following the presentation.
Webcast Details:
The presentation and Q&A session will be conducted in English. You can view the
live event by registering here: https://forms.office.com/e/iBe6HkGYmW.
Missed the Live Session?
A recording of the presentation will be available shortly after the event on our
financial reports page: https://www.lytixbiopharma.com/financial-reports.
For further information, please contact:
Gjest Breistein, CFO
Email: gjest.breistein@lytixbiopharma.com